IL134773A - Use for budesonide and formoterol - Google Patents

Use for budesonide and formoterol

Info

Publication number
IL134773A
IL134773A IL13477398A IL13477398A IL134773A IL 134773 A IL134773 A IL 134773A IL 13477398 A IL13477398 A IL 13477398A IL 13477398 A IL13477398 A IL 13477398A IL 134773 A IL134773 A IL 134773A
Authority
IL
Israel
Prior art keywords
formoterol
budesonide
relates
treating copd
copd
Prior art date
Application number
IL13477398A
Other languages
English (en)
Other versions
IL134773A0 (en
Inventor
Carl-Axel Bauer
Jan Trofast
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20408325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL134773(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL134773A0 publication Critical patent/IL134773A0/xx
Publication of IL134773A publication Critical patent/IL134773A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13477398A 1997-09-19 1998-09-09 Use for budesonide and formoterol IL134773A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9703407A SE9703407D0 (sv) 1997-09-19 1997-09-19 New use
PCT/SE1998/001599 WO1999015182A1 (fr) 1997-09-19 1998-09-09 Nouveaux emplois de la budesonide et du formoterol

Publications (2)

Publication Number Publication Date
IL134773A0 IL134773A0 (en) 2001-04-30
IL134773A true IL134773A (en) 2005-03-20

Family

ID=20408325

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13477398A IL134773A (en) 1997-09-19 1998-09-09 Use for budesonide and formoterol

Country Status (38)

Country Link
US (2) US7897646B2 (fr)
EP (2) EP1014993B1 (fr)
JP (1) JP2001517630A (fr)
KR (1) KR20010024140A (fr)
CN (1) CN1149998C (fr)
AR (1) AR013506A1 (fr)
AT (2) ATE329599T1 (fr)
AU (1) AU757235B2 (fr)
BR (1) BR9812325A (fr)
CA (1) CA2302700C (fr)
CY (1) CY1106156T1 (fr)
CZ (1) CZ295250B6 (fr)
DE (2) DE69807239T2 (fr)
DK (2) DK1210943T3 (fr)
EE (1) EE04297B1 (fr)
ES (2) ES2182357T3 (fr)
HK (1) HK1045812B (fr)
HU (1) HUP0003848A2 (fr)
ID (1) ID24838A (fr)
IL (1) IL134773A (fr)
IN (1) IN190791B (fr)
IS (1) IS2715B (fr)
MX (1) MXPA00002615A (fr)
MY (1) MY127812A (fr)
NO (1) NO327176B1 (fr)
NZ (1) NZ503173A (fr)
PL (1) PL190782B1 (fr)
PT (2) PT1014993E (fr)
RU (1) RU2199322C2 (fr)
SA (1) SA98190773B1 (fr)
SE (1) SE9703407D0 (fr)
SI (2) SI1014993T1 (fr)
SK (1) SK285330B6 (fr)
TR (1) TR200000726T2 (fr)
TW (1) TW546140B (fr)
UA (1) UA72446C2 (fr)
WO (1) WO1999015182A1 (fr)
ZA (1) ZA988516B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
CZ303154B6 (cs) * 1998-11-13 2012-05-09 Jagotec Ag Suchá prášková formulace k inhalaci obsahující stearát horecnatý
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9928311D0 (en) * 1999-11-30 2000-01-26 Novartis Ag Organic compounds
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
GB0012261D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
JP5154732B2 (ja) * 2001-02-06 2013-02-27 イノバータ・バイオメッド・リミテッド 薬剤
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
SE0200312D0 (sv) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
JP2006503865A (ja) * 2002-09-30 2006-02-02 アキュスフィア， インコーポレイテッド 吸入のための徐放性の多孔性微粒子
US6962006B2 (en) * 2002-12-19 2005-11-08 Acusphere, Inc. Methods and apparatus for making particles using spray dryer and in-line jet mill
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US7829554B2 (en) 2005-07-14 2010-11-09 Lithera, Inc. Sustained release enhanced lipolytic formulation for regional adipose tissue treatment
CA2631492A1 (fr) * 2005-12-15 2007-06-21 Acusphere, Inc. Procedes de preparation de formulations pharmaceutiques a base de particules destinees a une administration orale
US7913223B2 (en) * 2005-12-16 2011-03-22 Dialogic Corporation Method and system for development and use of a user-interface for operations, administration, maintenance and provisioning of a telecommunications system
GB0604141D0 (en) * 2006-03-01 2006-04-12 Arrow Int Ltd Nebulizer formulation
MX2009004198A (es) * 2006-10-17 2009-10-19 Lithera Inc Metodos, composiciones y formulaciones para el tratamiento de enfermedad ocular tiroidea.
US9132084B2 (en) * 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
ES2774391T3 (es) 2009-05-29 2020-07-20 Pearl Therapeutics Inc Composiciones, métodos y sistemas para la administración respiratoria de dos o más agentes activos
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
WO2010144628A2 (fr) * 2009-06-09 2010-12-16 Elevation Pharmaceuticals, Inc. Traitement d'une maladie pulmonaire obstructive chronique par administration de bêta 2 agoniste nébulisé ou d'une combinaison de bêta 2 agoniste nébulisé et d'anticholinergique
CN102000090A (zh) * 2009-08-31 2011-04-06 北京利乐生制药科技有限公司 一种以布地奈德与阿福特罗为活性成分的复方制剂
EP2523667A4 (fr) * 2010-01-15 2014-04-02 Lithera Inc Préparations pour gâteaux lyophilisés
KR20140025312A (ko) 2010-11-24 2014-03-04 리쎄라 인코오포레이티드 지방증 및 윤곽 팽창의 미용적 치료를 위한 선택적인, 친유성, 및 지속성 베타 작용제 단일치료 제형 및 방법
US9585930B2 (en) 2011-03-20 2017-03-07 Trustees Of Boston University Therapeutic agent for emphysema and COPD
CN102362860A (zh) * 2011-10-27 2012-02-29 江阴长风医药科技有限公司 以氢氟烷烃为抛射剂的布地奈德和福莫特罗气雾剂制剂
RU2696582C2 (ru) 2013-03-15 2019-08-05 Перл Терапьютикс, Инк. Способы и системы кондиционирования дисперсных кристаллических материалов
ITMI20130571A1 (it) * 2013-04-10 2014-10-11 Zambon Spa Composizione farmaceutica contenente budesonide e formoterolo
WO2015065220A1 (fr) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Préparation inhalable pour le traitement de l'asthme bronchial et de maladies à obstruction chronique des poumons, et procédé de production
GB201321712D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Dry Powder Inhaler
GB201321717D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
GB201408387D0 (en) * 2014-05-12 2014-06-25 Teva Pharmaceuticals Europ B V Treatment of respiratory disorders
BR112018011266B1 (pt) 2015-12-04 2023-11-21 Mexichem Fluor S.A. De C.V. Composição farmacêutica, recipiente vedado, e, métodos para tratar um paciente que sofre ou é propenso a sofrer de um distúrbio respiratório e para estabilizar uma composição farmacêutica
JP7470646B2 (ja) 2018-06-14 2024-04-18 アストラゼネカ・ユーケイ・リミテッド コルチコステロイド医薬組成物を用いて喘息の症状を治療および予防するための方法
WO2021048171A1 (fr) * 2019-09-10 2021-03-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Procédé d'amélioration de la phagocytose

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95590A (en) 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
DK0416950T3 (da) 1989-09-08 1993-10-11 Glaxo Group Ltd Medikamenter
US5250286A (en) 1990-05-07 1993-10-05 Aegis Technology, Inc. Treatment of chronic obstructive pulmonary disease (COPD) by inhalation of an imidazoline
PL164294B1 (pl) 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
US5795564A (en) 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5444521A (en) 1991-07-15 1995-08-22 Canon Kabushiki Kaisha Image fixing device capable of controlling heating overshoot
AU673660C (en) * 1991-12-18 2002-07-25 Astrazeneca Ab New combination of formoterol and budesonide
EP0613371B1 (fr) 1991-12-18 2002-03-06 AstraZeneca AB Nouvelle combinaison de formoterol et de budesonide
SE9404080L (sv) 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
SE9700134D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
GB9519692D0 (en) 1995-09-27 1995-11-29 Quillin Helen Atomising nozzle
EP0876347B1 (fr) * 1995-11-24 2005-03-02 GlaxoSmithKline S.p.A. Derives de quinoline
SE9603669D0 (sv) 1996-10-08 1996-10-08 Astra Ab New combination
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
ID24063A (id) 1997-06-27 2000-07-06 Astra Ab Kombinasi obat anti asma
SE9703407D0 (sv) * 1997-09-19 1997-09-19 Astra Ab New use
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
SE9900834D0 (sv) 1999-03-09 1999-03-09 Astra Ab Novel combination

Also Published As

Publication number Publication date
KR20010024140A (ko) 2001-03-26
RU2199322C2 (ru) 2003-02-27
HUP0003848A2 (hu) 2001-08-28
US20020042404A1 (en) 2002-04-11
SI1210943T1 (sl) 2006-10-31
SE9703407D0 (sv) 1997-09-19
TR200000726T2 (tr) 2000-09-21
CZ2000950A3 (cs) 2000-06-14
ID24838A (id) 2000-08-24
NO327176B1 (no) 2009-05-04
AU9192898A (en) 1999-04-12
CN1271287A (zh) 2000-10-25
CY1106156T1 (el) 2011-06-08
TW546140B (en) 2003-08-11
ATE222106T1 (de) 2002-08-15
EP1210943A1 (fr) 2002-06-05
HK1045812B (zh) 2006-12-22
NO20001401D0 (no) 2000-03-17
CA2302700C (fr) 2010-11-23
DE69834955T2 (de) 2007-01-25
HK1045812A1 (en) 2002-12-13
EE04297B1 (et) 2004-06-15
DE69807239T2 (de) 2003-04-10
IS5407A (is) 2000-03-15
SK3892000A3 (en) 2000-12-11
US20060189587A9 (en) 2006-08-24
ES2266322T3 (es) 2007-03-01
SI1014993T1 (en) 2003-02-28
CA2302700A1 (fr) 1999-04-01
PT1014993E (pt) 2002-12-31
NZ503173A (en) 2001-08-31
MXPA00002615A (es) 2002-04-24
SK285330B6 (sk) 2006-11-03
WO1999015182A1 (fr) 1999-04-01
BR9812325A (pt) 2000-09-05
IN190791B (fr) 2003-08-23
CZ295250B6 (cs) 2005-06-15
DK1210943T3 (da) 2006-09-18
PL190782B1 (pl) 2006-01-31
US20110097282A1 (en) 2011-04-28
AU757235B2 (en) 2003-02-06
EP1014993B1 (fr) 2002-08-14
EP1014993A1 (fr) 2000-07-05
AR013506A1 (es) 2000-12-27
UA72446C2 (uk) 2005-03-15
DE69834955D1 (de) 2006-07-27
NO20001401L (no) 2000-03-17
US7897646B2 (en) 2011-03-01
EP1210943B1 (fr) 2006-06-14
ZA988516B (en) 1999-03-19
DE69807239D1 (de) 2002-09-19
IS2715B (is) 2011-02-15
EE200000145A (et) 2001-02-15
ATE329599T1 (de) 2006-07-15
CN1149998C (zh) 2004-05-19
PT1210943E (pt) 2006-09-29
PL339295A1 (en) 2000-12-04
MY127812A (en) 2006-12-29
US8461211B2 (en) 2013-06-11
JP2001517630A (ja) 2001-10-09
DK1014993T3 (da) 2002-11-11
SA98190773B1 (ar) 2006-10-02
ES2182357T3 (es) 2003-03-01
IL134773A0 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
IL134773A (en) Use for budesonide and formoterol
IL116479A0 (en) Antifungal compositions and bandage for treatment of nails
DE69518919D1 (de) Autoantikörper enthaltende zusammensetzung für tumorbehandlung und -vorbeugung
IL112603A0 (en) Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
IL136515A0 (en) Combination effective for the treatment of impotence
ZA931778B (en) Method and composition for the treatment of osteoporosis
ZA954984B (en) Compositions and methods for the treatment of tumors
HK1018271A1 (en) Substituted benzylamines and their use for the treatment of depression
GB9808936D0 (en) Combination therapy for the prevention and treatment of osteoporosis
FI961380A (fi) Koostumuksia virusten aiheuttamien kasvainten ehkäisemiseksi ja hoitamiseksi
HK1022267A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis
ATA125094A (de) Verfahren und anlage zur direktreduktion von eisenoxidhältigem material
IL112469A0 (en) Composition for the treatment of an epidermal disorder
GB9400657D0 (en) Treatment of gas mixtures
ZA951226B (en) The treatment of gaseous substances
GB9424471D0 (en) Treatment of emesis
IL109818A0 (en) Pharmaceutical compositions comprising iron chelators for the treatment of neurodegenerative disorders and some novel iron chelators
GB2288343B (en) The treatment of gas streams
ZA959807B (en) Antidote composition and method for use of the composition
GB9716883D0 (en) Combination therapy for the prevention and treatent of osteoporosis
ZA9510717B (en) Treatment of gaseous emissions
ZA951440B (en) Novel opiold peptides for the treatment of pain and use thereof
GB9410605D0 (en) Treatment of gas

Legal Events

Date Code Title Description
FF Patent granted
EXTN Extension order renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired